- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book charts the history and development of one of the most important medical substances of the twentieth century, Interferon, as a drug.
Andere Kunden interessierten sich auch für
- Shifting Boundaries of Public Health40,99 €
- Logical Empiricism and the Physical Sciences60,99 €
- The Archaeology of Medicine and Healthcare58,99 €
- The History of Pharmacy51,99 €
- Geography of Innovation60,99 €
- Cristina BelloriniThe World of Plants in Renaissance Tuscany61,99 €
- Thomas BoylanBeyond Rhetoric and Realism in Economics116,99 €
-
-
-
This book charts the history and development of one of the most important medical substances of the twentieth century, Interferon, as a drug.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 284
- Erscheinungstermin: 12. September 2012
- Englisch
- Abmessung: 234mm x 156mm x 15mm
- Gewicht: 404g
- ISBN-13: 9780415648660
- ISBN-10: 0415648661
- Artikelnr.: 36539748
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 284
- Erscheinungstermin: 12. September 2012
- Englisch
- Abmessung: 234mm x 156mm x 15mm
- Gewicht: 404g
- ISBN-13: 9780415648660
- ISBN-10: 0415648661
- Artikelnr.: 36539748
Toine Peters is senior research fellow at the Department of Metamedica of the VU University Medical Centre, Amsterdam, and Professor of History of Pharmacy at Groningen University, the Netherlands.
Introduction 1. Interferon's Birth Starting a British/Swiss collaboration
in a London laboratory Intimate interplay between thought and action in
Room 215 Writing 'Interferon' Isaac's Interferon Kitchen 2. Shaping a New
Field of Research: Investigating Interferon(s) Interferon going public The
Antiviral Penicillin Misinterpretation From the brink to revival: meeting
the others Debating Interferon's mode of operation: the specificity effect
What's in a name? The blossoming of a new subfield 3. Interferon on Trial A
partnership originating in national interests Establishing a collaborative
programme for research on Interferon Preparations for an early trial in
volunteers Handling production and safety problems The Lancet report
Interferon losing its momentum No 'magic bullet' 4. Managing Differences
Portrait of a 'gift culture' Creating a breeding-ground for standardization
An experiment in scientific communication Safeguarding British interests A
Finnish detour Wrestling standards 'Having to haul down one's colours' 5.
About Mice, Malignancies and Experimental Therapies Interfering with cancer
Hoping for patients to behave like laboratory mice Mathilde Krim's
Interferon lobby Staging a workshop on Interferon in the treatment of
cancer Attempts to put Interferon on the cancer map 6. Interferon,
Audiences and Cancer Capitalizing on a growing demand for unorthodox cancer
remedies Interferon, scientists and the media Hailing a miracle drug Gene
dreams and the inflation of expectations Coping with an imminent black
market 7. Yet Another Twist: Marketing Interferon as a Helpful Neighbour
Beyond Interferon A drug looking for a disease Naturalizing Interferons as
biological response modifiers and cytokines 8. Interferons in Retrospect
and Prospect Patients at work Crafting Interferon(s) Seeking 'magic
bullets' 'Doctoring' the media Toward genetic medicine Patients at risk?
in a London laboratory Intimate interplay between thought and action in
Room 215 Writing 'Interferon' Isaac's Interferon Kitchen 2. Shaping a New
Field of Research: Investigating Interferon(s) Interferon going public The
Antiviral Penicillin Misinterpretation From the brink to revival: meeting
the others Debating Interferon's mode of operation: the specificity effect
What's in a name? The blossoming of a new subfield 3. Interferon on Trial A
partnership originating in national interests Establishing a collaborative
programme for research on Interferon Preparations for an early trial in
volunteers Handling production and safety problems The Lancet report
Interferon losing its momentum No 'magic bullet' 4. Managing Differences
Portrait of a 'gift culture' Creating a breeding-ground for standardization
An experiment in scientific communication Safeguarding British interests A
Finnish detour Wrestling standards 'Having to haul down one's colours' 5.
About Mice, Malignancies and Experimental Therapies Interfering with cancer
Hoping for patients to behave like laboratory mice Mathilde Krim's
Interferon lobby Staging a workshop on Interferon in the treatment of
cancer Attempts to put Interferon on the cancer map 6. Interferon,
Audiences and Cancer Capitalizing on a growing demand for unorthodox cancer
remedies Interferon, scientists and the media Hailing a miracle drug Gene
dreams and the inflation of expectations Coping with an imminent black
market 7. Yet Another Twist: Marketing Interferon as a Helpful Neighbour
Beyond Interferon A drug looking for a disease Naturalizing Interferons as
biological response modifiers and cytokines 8. Interferons in Retrospect
and Prospect Patients at work Crafting Interferon(s) Seeking 'magic
bullets' 'Doctoring' the media Toward genetic medicine Patients at risk?
Introduction 1. Interferon's Birth Starting a British/Swiss collaboration
in a London laboratory Intimate interplay between thought and action in
Room 215 Writing 'Interferon' Isaac's Interferon Kitchen 2. Shaping a New
Field of Research: Investigating Interferon(s) Interferon going public The
Antiviral Penicillin Misinterpretation From the brink to revival: meeting
the others Debating Interferon's mode of operation: the specificity effect
What's in a name? The blossoming of a new subfield 3. Interferon on Trial A
partnership originating in national interests Establishing a collaborative
programme for research on Interferon Preparations for an early trial in
volunteers Handling production and safety problems The Lancet report
Interferon losing its momentum No 'magic bullet' 4. Managing Differences
Portrait of a 'gift culture' Creating a breeding-ground for standardization
An experiment in scientific communication Safeguarding British interests A
Finnish detour Wrestling standards 'Having to haul down one's colours' 5.
About Mice, Malignancies and Experimental Therapies Interfering with cancer
Hoping for patients to behave like laboratory mice Mathilde Krim's
Interferon lobby Staging a workshop on Interferon in the treatment of
cancer Attempts to put Interferon on the cancer map 6. Interferon,
Audiences and Cancer Capitalizing on a growing demand for unorthodox cancer
remedies Interferon, scientists and the media Hailing a miracle drug Gene
dreams and the inflation of expectations Coping with an imminent black
market 7. Yet Another Twist: Marketing Interferon as a Helpful Neighbour
Beyond Interferon A drug looking for a disease Naturalizing Interferons as
biological response modifiers and cytokines 8. Interferons in Retrospect
and Prospect Patients at work Crafting Interferon(s) Seeking 'magic
bullets' 'Doctoring' the media Toward genetic medicine Patients at risk?
in a London laboratory Intimate interplay between thought and action in
Room 215 Writing 'Interferon' Isaac's Interferon Kitchen 2. Shaping a New
Field of Research: Investigating Interferon(s) Interferon going public The
Antiviral Penicillin Misinterpretation From the brink to revival: meeting
the others Debating Interferon's mode of operation: the specificity effect
What's in a name? The blossoming of a new subfield 3. Interferon on Trial A
partnership originating in national interests Establishing a collaborative
programme for research on Interferon Preparations for an early trial in
volunteers Handling production and safety problems The Lancet report
Interferon losing its momentum No 'magic bullet' 4. Managing Differences
Portrait of a 'gift culture' Creating a breeding-ground for standardization
An experiment in scientific communication Safeguarding British interests A
Finnish detour Wrestling standards 'Having to haul down one's colours' 5.
About Mice, Malignancies and Experimental Therapies Interfering with cancer
Hoping for patients to behave like laboratory mice Mathilde Krim's
Interferon lobby Staging a workshop on Interferon in the treatment of
cancer Attempts to put Interferon on the cancer map 6. Interferon,
Audiences and Cancer Capitalizing on a growing demand for unorthodox cancer
remedies Interferon, scientists and the media Hailing a miracle drug Gene
dreams and the inflation of expectations Coping with an imminent black
market 7. Yet Another Twist: Marketing Interferon as a Helpful Neighbour
Beyond Interferon A drug looking for a disease Naturalizing Interferons as
biological response modifiers and cytokines 8. Interferons in Retrospect
and Prospect Patients at work Crafting Interferon(s) Seeking 'magic
bullets' 'Doctoring' the media Toward genetic medicine Patients at risk?